Global Pharma Streamlines MLR Process to Accelerate Time to Market

Download PDFDownload PDFTalk to UsTalk to Us

The Customer

A global pharmaceutical leader in Neurology, managing over 20 brands across 100+ countries.

MLR process optimization in a global pharma organization

The Challenges

MLR review inefficiencies were slowing down content readiness and market responsiveness.

  1. Changes in content consumption trends led to a 3X increase in materials needing MLR approval.

  2. Existing MLR capacity couldn’t keep up, causing delays and frequent non-compliance with turnaround SLAs.

  3. Slower Future of Content Review in Life Sciences Organizationscontent approvals meant missed opportunities in brand promotion and HCP engagement.

  4. Without automation or standardization, 20% of assets had errors post-production, requiring rework and risking compliance.

The Solution

Comprehensive process diagnostics

Via documentation review, interviews and benchmarking against best-in-class industry practices.

Gap analysis

Uncovered 20+ gaps identified across material quality, review efficiency, people, and scalability.

Strategic Roadmap

Delivered 15+ actionable recommendations, balancing quick wins with long-term improvements.

Outcomes

  • Faster time to market leading to reduction in business opportunity cost

  • Reduction in review cycles due to improved quality of assets

  • Elimination of errors in postproduction files

  • Reduction in review costs due to improved productivity and leaner content review

28%

Reduction in the lead Customizing MLR Approval Processes with Tier-based Innovationtime for approval

35%

Growth in Right First Time

0

Post production errors

30%

Reduction in review costs

Featured Insights